Opus Genetics (IRD) EBIT (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.42% |
| Dec 31, 2025 | -37.81% |
| Sep 30, 2025 | 6.68% |
| Jun 30, 2025 | 10.30% |
| Mar 31, 2025 | 73.89% |
| Dec 31, 2024 | -374.83% |
| Sep 30, 2024 | 3.83% |
| Jun 30, 2024 | -8.04% |
| Mar 31, 2024 | -41.98% |
| Dec 31, 2023 | -185.01% |
| Sep 30, 2023 | 218.50% |
| Jun 30, 2023 | 12.10% |
| Mar 31, 2023 | -117.92% |
| Dec 31, 2022 | 853.86% |
| Sep 30, 2022 | 8.10% |
| Jun 30, 2022 | 24.12% |
| Mar 31, 2022 | -5.82% |
| Dec 31, 2021 | -45.32% |
| Sep 30, 2021 | 40.70% |
| Jun 30, 2021 | -37.62% |
| Mar 31, 2021 | 63.02% |
| Dec 31, 2020 | -619.87% |
| Sep 30, 2020 | -54.36% |
| Jun 30, 2020 | 53.86% |
| Mar 31, 2020 | -154.55% |
| Dec 31, 2019 | 319.84% |
| Sep 30, 2019 | 23.68% |
| Jun 30, 2019 | 24.11% |
| Mar 31, 2019 | 20.71% |
| Dec 31, 2018 | -6.03% |
| Sep 30, 2018 | 6.35% |
| Jun 30, 2018 | 15.03% |
| Mar 31, 2018 | -20.16% |
| Dec 31, 2017 | -16.09% |
| Sep 30, 2017 | 1.51% |
| Jun 30, 2017 | -8.36% |
| Mar 31, 2017 | -0.87% |
| Dec 31, 2016 | -5.42% |
| Sep 30, 2016 | 4.99% |
| Jun 30, 2016 | 19.56% |
| Mar 31, 2016 | -11.37% |
| Dec 31, 2015 | 6.25% |
| Sep 30, 2015 | 3.35% |
| Jun 30, 2015 | -9.10% |
| Mar 31, 2015 | -14.67% |
| Dec 31, 2014 | -22.62% |
| Sep 30, 2014 | 10.47% |
| Jun 30, 2014 | -26.86% |
| Mar 31, 2014 | -18.59% |
| Dec 31, 2013 | -27.88% |
| Sep 30, 2013 | 4.68% |
| Jun 30, 2013 | -0.24% |
| Mar 31, 2013 | -82.40% |
| Dec 31, 2012 | 41.85% |
| Sep 30, 2012 | 2.66% |
| Jun 30, 2012 | 1.87% |
| Mar 31, 2012 | 21.62% |
| Dec 31, 2011 | 28.35% |
| Sep 30, 2011 | 48.05% |
| Jun 30, 2011 | -65.04% |
| Mar 31, 2011 | -23.99% |
| Dec 31, 2010 | -33.31% |
| Sep 30, 2010 | 25.76% |